Mdp derivatives and conjugates having haematopoietic...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 5/037 (2006.01) A61K 31/505 (2006.01) A61K 31/70 (2006.01) A61K 38/05 (2006.01) A61K 38/06 (2006.01) A61K 47/18 (2006.01) C07K 5/062 (2006.01) C07K 9/00 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2216599

A pharmaceutical composition for stimulating the haematopoietic function and preventing the myelotoxic side-effects of some treatments, containing at least one water-soluble muramyl peptide derivative such as Muradimetide, muroctasine or MTP-PE.

Composition pharmaceutique destinée à stimuler la fonction hématopoïetique et prévenir les effets myélotoxiques de certains traitements contenant au moins un dérivé hydrosoluble de muramyl peptide comme par exemple le Muradimétide, la murocstasine ou le MTP-PE.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mdp derivatives and conjugates having haematopoietic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mdp derivatives and conjugates having haematopoietic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mdp derivatives and conjugates having haematopoietic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1573277

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.